These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 9528762)
1. A differential screen for ligand-regulated genes: identification of HoxA10 as a target of vitamin D3 induction in myeloid leukemic cells. Rots NY; Liu M; Anderson EC; Freedman LP Mol Cell Biol; 1998 Apr; 18(4):1911-8. PubMed ID: 9528762 [TBL] [Abstract][Full Text] [Related]
2. Direct regulation of HOXA10 by 1,25-(OH)2D3 in human myelomonocytic cells and human endometrial stromal cells. Du H; Daftary GS; Lalwani SI; Taylor HS Mol Endocrinol; 2005 Sep; 19(9):2222-33. PubMed ID: 15905361 [TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1). Muto A; Kizaki M; Yamato K; Kawai Y; Kamata-Matsushita M; Ueno H; Ohguchi M; Nishihara T; Koeffler HP; Ikeda Y Blood; 1999 Apr; 93(7):2225-33. PubMed ID: 10090931 [TBL] [Abstract][Full Text] [Related]
4. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression. Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697 [TBL] [Abstract][Full Text] [Related]
6. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102 [TBL] [Abstract][Full Text] [Related]
7. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements. Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990 [TBL] [Abstract][Full Text] [Related]
8. Monocytic differentiation of acute promyelocytic leukemia cells in response to 1,25-dihydroxyvitamin D3 is independent of nuclear receptor binding. Bhatia M; Kirkland JB; Meckling-Gill KA J Biol Chem; 1995 Jul; 270(27):15962-5. PubMed ID: 7608152 [TBL] [Abstract][Full Text] [Related]
9. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. Kim S; Shevde NK; Pike JW J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of 1,25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant. Narvaez CJ; Welsh J Endocrinology; 1997 Nov; 138(11):4690-8. PubMed ID: 9348195 [TBL] [Abstract][Full Text] [Related]
11. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element. Imai Y; Pike JW; Koeffler HP Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077 [TBL] [Abstract][Full Text] [Related]
12. 1,25(OH)2-vitamin D3 mediated changes in mRNA for c-myc and 1,25(OH)2D3 receptor in HL-60 cells and related subclones. Taoka T; Collins ED; Irino S; Norman AW Mol Cell Endocrinol; 1993 Sep; 95(1-2):51-7. PubMed ID: 8243807 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D and systemic cancer: is this relevant to malignant melanoma? Osborne JE; Hutchinson PE Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089 [TBL] [Abstract][Full Text] [Related]
14. 1 alpha,25-Dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro. Elstner E; Lee YY; Hashiya M; Pakkala S; Binderup L; Norman AW; Okamura WH; Koeffler HP Blood; 1994 Sep; 84(6):1960-7. PubMed ID: 8080998 [TBL] [Abstract][Full Text] [Related]
15. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells. Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613 [TBL] [Abstract][Full Text] [Related]
16. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes. Ellison TI; Eckert RL; MacDonald PN J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066 [TBL] [Abstract][Full Text] [Related]
17. Anticoagulant effects of 1alpha,25-dihydroxyvitamin D3 on human myelogenous leukemia cells and monocytes. Koyama T; Shibakura M; Ohsawa M; Kamiyama R; Hirosawa S Blood; 1998 Jul; 92(1):160-7. PubMed ID: 9639512 [TBL] [Abstract][Full Text] [Related]
18. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Kreutz M; Andreesen R; Krause SW; Szabo A; Ritz E; Reichel H Blood; 1993 Aug; 82(4):1300-7. PubMed ID: 8394753 [TBL] [Abstract][Full Text] [Related]
19. 1alpha,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1alpha,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells. Siu-Caldera ML; Clark JW; Santos-Moore A; Peleg S; Liu YY; Uskoković MR; Sharma S; Reddy GS J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):405-12. PubMed ID: 9010346 [TBL] [Abstract][Full Text] [Related]
20. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. Mangelsdorf DJ; Koeffler HP; Donaldson CA; Pike JW; Haussler MR J Cell Biol; 1984 Feb; 98(2):391-8. PubMed ID: 6319426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]